Lenvatinib and pembrolizumab in patients with metastatic papillary renal cell carcinoma: A phase 2 pilot study.

被引：0
|
作者：
Tsimafeyeu, Ilya [1 ]
Sultanbaev Sr, Alexander [2 ]
Vilkov, Sergey
机构：
[1] Republican Clin Oncol Dispensary, Ufa, Russia
[2] Hadassah Med, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 23_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.23_suppl.109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
109
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Phase 2 study of pembrolizumab plus lenvatinib and belzutifan in patients with metastatic esophageal squamous cell carcinoma.
    Rojas, Carlos
    Ryoo, Baek-Yeol
    Rha, Sun Young
    Kelley, Robin Kate
    Hubert, Ayala
    Painemal, Claudio
    Wadlow, Raymond Couric
    Gong, Jun
    Fan, Li
    Jin, Fan
    Naik, Girish S.
    Macarulla, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS425 - TPS425
  • [2] The implementation of lenvatinib/everolimus or lenvatinib/pembrolizumab combinations in the treatment of metastatic renal cell carcinoma
    Jacob, Allen
    Shook, Jaret
    Hutson, Thomas
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (04) : 365 - 372
  • [3] Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis
    Yamashita, Shimpei
    Kawabata, Hiroki
    Iwahashi, Yuya
    Muraoka, Satoshi
    Wakamiya, Takahito
    Kojima, Fumiyoshi
    Kohjimoto, Yasuo
    Murata, Shin-ichi
    Hara, Isao
    IJU CASE REPORTS, 2025,
  • [4] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma
    Lee, C-H.
    Makker, V.
    Rasco, D.
    Taylor, M.
    Dutcus, C.
    Shumaker, R.
    Schmidt, E. V.
    Stepan, D.
    Li, D.
    Motzer, R. J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] A Phase IB/II Trial of Lenvatinib plus Pembrolizumab in Patients With Renal Cell Carcinoma
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Matthew
    Dutcus, Corina
    Shumaker, Robert
    Schmidt, Emmett
    Stepan, Daniel E.
    Li, Di
    Young, Louise
    Motzer, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 153 - 153
  • [6] Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan
    Menshiko, K. V.
    Lipatov, D. O.
    Nasretdinov, A. F.
    Musin, Sh. I.
    Sultanbaeva, N. I.
    Menshikov, I. A.
    Sultanbae, A. V.
    Izmaylov, A. A.
    Galimo, Sh. N.
    Rezyapova, A. Sh.
    ONKOUROLOGIYA, 2024, 19 (02):
  • [7] Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study
    Matsubara, Nobuaki
    Naito, Yoichi
    Nakano, Kenji
    Fujiwara, Yutaka
    Ikezawa, Hiroki
    Yusa, Wataru
    Namiki, Masayuki
    Okude, Takashi
    Takahashi, Shunji
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (11) : 922 - 928
  • [8] Lenvatinib plus Pembrolizumab for Renal Cell Carcinoma
    Hindie, Elif
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 287 - 287
  • [9] Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Mathew
    Stepan, Daniel E.
    Shumaker, Robert
    Schmidt, Emmett V.
    Guo, Matthew
    Dutcus, Corina
    Young, Louise
    Motzer, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 174 - 175
  • [10] Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
    Volkova, M., I
    Kalpinskiy, A. S.
    Goncharova, O. A.
    Menshikov, K. V.
    Stativko, O. A.
    Karabina, E. V.
    Dergunov, A. S.
    Polshina, N. I.
    Aleksandrova, E. N.
    Lebedinets, A. A.
    Panov, A. K.
    Sultanbaev, A. V.
    Usynin, E. A.
    Volkonsky, M. V.
    Mikhalyuk, V. V.
    Zukov, R. A.
    Anzhiganova, Yu. V.
    Gusniev, M. A.
    Igumnova, E. N.
    Kuzmicheva, S. V.
    Pokataev, I. A.
    Olshanskaya, A. S.
    Pervakova, N. I.
    Parsadanova, E. L.
    Sannikova, T. A.
    Bystrov, A. A.
    Dubovichenko, D. M.
    Mukhitova, M. R.
    Chubenko, V. A.
    Shkret, K. A.
    Gorshenina, M. N.
    Semenov, A. V.
    Davlatova, M. K.
    Kosareva, A. E.
    Lutoshkina, O. A.
    Maslova, O. A.
    Makhnutina, M. V.
    Mishina, A. V.
    Murzalina, M. Zh.
    Podyacheva, O. A.
    Kalinin, S. A.
    Mailyan, O. A.
    Safarova, A. R.
    Semenova, K. O.
    Strokova, M. A.
    Urashkina, E. Yu.
    Shmygina, O. S.
    Novikova, O. Yu.
    ONKOUROLOGIYA, 2024, 20 (03):
12345